3 Best Stocks to Buy Now, 9/24/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 9/24/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Avidity Biosciences (RNA) – Avidity Biosciences is focused on delivering a new class of targeted RNA therapeutics to address unmet patient needs. Today, Goldman Sachs analyst Corinne Johnson initiated a Buy rating on the stock with a price target of $59. In the last three months, all the eight Top Analysts covering the stock have rated it a Buy. The average 12-month price target for RNA stock implies an upside of about 38.5%.

Uber Technologies (UBER) – Uber provides a ride-sharing and food delivery platform. Yesterday, Raymond James analyst Josh Beck initiated a Buy rating on the stock with a price target of $90. In the last three months, all the 29 Top Analysts covering the stock have rated it a Buy. Taken together, the average of their 12-month price targets implies an upside of about 20.1%.

News Corp (NWSA) – News Corp is a media and information services company. Yesterday, Loop Capital analyst Alan Gould reiterated a Buy rating on the stock with a price target of $39. In the last three months, all the three Top Analysts covering the stock have rated it a Buy. Altogether, the average of their 12-month price targets implies an upside of about 40%.

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
Brian AndersonRNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
TheFlyAvidity Biosciences price target raised to $65 from $60 at Chardan
TheFlyAvidity begins a biomarker cohort in the Phase 1/2 FORTITUDE trial
Go Ad-Free with Our App